Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 2077, Suchdauer: 0.71s

12 3 4 5 6 7 8 9 10 11 weiter »

1
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach

von King, Brett ; Senna, Maryanne ; Ohyama, Manabu ; et al.

Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. :1-11
- Zum Volltext in PubMed Central
Merkliste

2
Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata

von King, Brett ; McMichael, Amy ; Sinclair, Rodney ; et al.

Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. 15(12):3793-3803
- Zum Volltext in PubMed Central
Merkliste

3
Alopecia areata

von Ungar, Benjamin ; Renert-Yuval, Yael ; Dlova, Ncoza C. ; et al.

Nature Reviews Disease Primers. 11(1)
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

4
Indonesian dreadlock hair: a novel presentation of hair shaft disorders

von Sari, Agnes Rosarina Prita ; Shelly, Wan Gifanni Efmadian ; Asifa, Nadia Nur ; et al.

Archives of Dermatological Research: Founded in 1869 as Archiv für Dermatologie und Syphilis. 317(1)
- Zum Volltext (via ReDI)
Merkliste

5
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment

von King, Brett ; Mostaghimi, Arash ; Shimomura, Yutaka ; et al.

American Journal of Clinical Dermatology. 26(4):611-622
- Zum Volltext (via ReDI)
Merkliste

6
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2

von Senna, Maryanne ; Mostaghimi, Arash ; Sinclair, Rodney ; et al.

In Journal of the American Academy of Dermatology April 2026 94(4):1126-1133
- View full text via DOI
Merkliste

7
Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations

von Dias, Flavia Rodrigues ; Yong, Shin Shen ; FitzGerald, Holly ; et al.

Frontiers in Pharmacology ; volume 16 ; ISSN 1663-9812
- View full text via BASE
Merkliste

8
Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial

von Tang, Gia Toan ; Leemaqz, Shalem ; Bhoyrul, Bevin ; et al.

In Journal of the American Academy of Dermatology May 2026
- View full text via DOI
Merkliste

9
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial

von Sinclair, Rodney ; Mesinkovska, Natasha ; Mitra, Debanjali ; et al.

American Journal of Clinical Dermatology. 26(1):109-119
- Zum Volltext (via ReDI)
Merkliste

10
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

von King, Brett ; Soung, Jennifer ; Tziotzios, Christos ; et al.

American Journal of Clinical Dermatology. 26(6):1065-1065
- Zum Volltext (via ReDI)
Merkliste

11
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial

von Piliang, Melissa ; Lynde, Charles ; King, Brett ; et al.

In Journal of the American Academy of Dermatology February 2025 92(2):276-284
- View full text via DOI
Merkliste

12
Summation and recommendations for the safe and effective use of topical and oral minoxidil

von Olsen, Elise A. ; Sinclair, Rodney ; Hordinsky, Maria ; et al.

In Journal of the American Academy of Dermatology April 2025
- View full text via DOI
Merkliste

13
Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial

von Natasha Atanaskova Mesinkovska ; Brett A. King ; Sergio Vañó‐Galván ; et al.

JEADV Clinical Practice, Vol 3, Iss 2, Pp 528-535 (2024)

Schlagworte: alopecia areata; baricitinib; hair loss; JAK inhibitor; SALT; Severity of Alopecia Tool; Dermatology; RL1-803; Diseases of the genitourinary system. Urology; RC870-923
- View full text via DOI
Merkliste

14
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

von King, Brett ; Soung, Jennifer ; Tziotzios, Christos ; et al.

American Journal of Clinical Dermatology. 25(2):299-314
- Zum Volltext (via ReDI)
Merkliste

15
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

16
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss

von Akiska, Yagiz Matthew ; Mirmirani, Paradi ; Roseborough, Ingrid ; et al.

JAMA Dermatology, vol 161, iss 1

Schlagworte: 32 Biomedical and Clinical Sciences (for-2020); 3202 Clinical Sciences (for-2020); 42 Health Sciences (for-2020); Pediatric (rcdc); Patient Safety (rcdc); 6.1 Pharmaceuticals (hrcs-rac); Humans (mesh); Minoxidil (mesh); Alopecia (mesh); Delphi Technique (mesh); Administration; Oral (mesh); Off-Label Use (mesh); Consensus (mesh); Child (mesh); Adolescent (mesh); Adult (mesh); Vasodilator Agents (mesh); 1103 Clinical Sciences (for); 1112 Oncology and Carcinogenesis (for)
- View full text via BASE
Merkliste

17
A Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: A Single-Arm Clinical Trial of Feasibility

von Matthew A. Petoe, BEng (Hons), PhD ; Carla J. Abbott, BOptom, PhD ; Samuel A. Titchener, BEng (Hons), PhD ; et al.

Ophthalmology Science, Vol 5, Iss 1, Pp 100525- (2025)

Schlagworte: Suprachoroidal retinal prosthesis; Functional vision; Bionic eye; Retinitis pigmentosa; Activities of daily living; Ophthalmology; RE1-994
- View full text via DOI
Merkliste

18
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

19
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata

von Senna, Maryanne M. ; Kwon, Ohsang ; Piraccini, Bianca M. ; et al.

Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. 13(12):3209-3220
- Zum Volltext in PubMed Central
Merkliste

20
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024

von Meah, Nekma ; Li, Jane ; Wall, Dmitri ; et al.

Journal of the European Academy of Dermatology and Venereology

Schlagworte: 32 Biomedical and Clinical Sciences (for-2020); 3202 Clinical Sciences (for-2020); consensus; Delphi; frontal fibrosing alopecia; therapeutic guideline; 1103 Clinical Sciences (for); Dermatology & Venereal Diseases (science-metrix)
- View full text via BASE
Merkliste

21
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

22
Rademikibart (CBP‐201), a next‐generation monoclonal antibody targeting human IL‐4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis

von Junying Wang ; Jeffery White ; Kenneth J. Sansone ; et al.

Clinical and Translational Science, Vol 16, Iss 12, Pp 2614-2627 (2023)

Schlagworte: Therapeutics. Pharmacology; RM1-950; Public aspects of medicine; RA1-1270
- View full text via DOI
Merkliste

23
Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise

von Thomas, Meryl ; Hankins, Madeline ; Darchini‐Maragheh, Emadodin ; et al.

Australasian Journal of Dermatology ; ISSN 0004-8380 1440-0960
- View full text via BASE
Merkliste

24
Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia

von Sinclair, Rodney ; Eisman, Samantha ; Lee, Carol M. Y. ; et al.

Australasian Journal of Dermatology ; volume 66, issue 4 ; ISSN 0004-8380 1440-0960
- View full text via BASE
Merkliste

25
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata

von Zhou, Cheng ; Yang, Xiumin ; Yang, Bin ; et al.

In Journal of the American Academy of Dermatology November 2023 89(5):911-919
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag